Wang Meng, Lim Poh Ying, Lee Khuan, Sowtali Siti Noorkhairina, Jiang Qiuhuan, Thew Hui Zhu
Department of Nursing, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
BMJ Open. 2025 Apr 21;15(4):e093191. doi: 10.1136/bmjopen-2024-093191.
In the management of medication adherence in elderly patients with type 2 diabetes mellitus (T2DM), traditional methods such as verbal guidance and written materials may have certain limitations. Therefore, the development of digital intervention measures may play a key role in addressing these shortcomings. The objective of this study is to investigate the effects of Diabetes Little Helper (DLH) video intervention in improving medication adherence among elderly patients with T2DM in Henan province, China.
A parallel cluster randomised controlled trial will be applied in the current study. The two hospitals will be randomly divided into a control group and an intervention group, with 68 patients in each arm. Both groups will receive standard care, meanwhile the intervention group will receive an additional DLH video intervention. Data collection is planned at baseline, 1 month after intervention and at 3-month follow-up. Once the study is completed, the control group will also receive the similar video as in the intervention arm to uphold the ethical issues.
This study has obtained ethical approval from the Institutional Review Board of University Putra Malaysia (JKEUPM-2023-1279) and Henan Provincial People's Hospital (20240107). The research results will also be submitted for publication in peer-reviewed journals.
Chinese Clinical Trial Registry, ChiCTR2400083282.
在老年2型糖尿病(T2DM)患者的药物依从性管理中,传统方法如口头指导和书面材料可能存在一定局限性。因此,开发数字干预措施可能在解决这些不足方面发挥关键作用。本研究的目的是调查糖尿病小助手(DLH)视频干预对提高中国河南省老年T2DM患者药物依从性的效果。
本研究将采用平行整群随机对照试验。两家医院将被随机分为对照组和干预组,每组68例患者。两组均接受标准护理,同时干预组将额外接受DLH视频干预。计划在基线、干预后1个月和3个月随访时收集数据。研究完成后,对照组也将接受与干预组类似的视频,以维护伦理问题。
本研究已获得马来西亚博特拉大学机构审查委员会(JKEUPM - 2023 - 1279)和河南省人民医院(20240107)的伦理批准。研究结果也将提交至同行评审期刊发表。
中国临床试验注册中心,ChiCTR2400083282。